Jeong Heo

South Korea

Research Interests

Explore related searches

Professors in South Korea

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (19)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (7)

Ki Tae Yoon

Assistant Professor

Pusan National University Yangsan Hospital

SOUTH KOREA

View details

hyung hoi kim

Professor

Pusan National University School of Medicine

SOUTH KOREA

View details

So Young Yoo

Pusan National University

SOUTH KOREA

View details

PIETRO ANDREONE

Professor of Medicine and Surgery

Università degli Studi di Roma Tor Vergata Facoltà di Medicina e Chirurgia

ITALY

View details

Anthony Brown

University of Oxford

UNITED KINGDOM

View details

Enrico N De Toni

University Hospital

GERMANY

View details

Carla S. Coffin

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jeong Heo

Research Interests

Explore related searches

Contact this professor

Articles (19)

Risk of HBV reactivation in HBV/HCV-co-infected HCV-treated patients: A single-center study

Reply to: “Sequential therapy with antisense oligonucleotide and immune modulator as a strategy for HBV cure”

Efficacy and safety of bintrafusp alfa in 2 phase I expansion cohorts with advanced HCC

Patient-Reported Outcomes From the Phase III HIMALAYA Study of Tremelimumab Plus Durvalumab in Unresectable Hepatocellular Carcinoma

Sequential Peg-IFN after bepirovirsen may reduce post-treatment relapse in chronic hepatitis B

Phase Ib/IIa randomized study of heterologous ChAdOx1-HBV/MVA-HBV therapeutic vaccination (VTP-300) as monotherapy and combined with low-dose nivolumab in virally-suppressed patients with CHB.

Outcome of Atezolizumab Plus Bevacizumab Combination Therapy in High-Risk Patients with Advanced Hepatocellular Carcinoma

Seroprevalence of Hepatitis C Virus Infection in North Korean Defectors Residing in Korea

Erratum: Correction of Text in the Article “Seroprevalence of Hepatitis C Virus Infection in North Korean Defectors Residing in Korea”

Safety and dose escalation of the targeted oncolytic adenovirus OBP-301 for refractory advanced liver cancer: Phase I clinical trial

Navigating through the PD-1/PDL-1 Landscape: A Systematic Review and Meta-Analysis of Clinical Outcomes in Hepatocellular Carcinoma and Their Influence on Immunotherapy and Tumor Microenvironment

Oncolytic virotherapy targeting the IL15 pathway

Primary hepatic sarcoidosis presenting with cholestatic liver disease and mimicking primary biliary cholangitis: a case report

Effect of switching from nucleos(t)ide maintenance therapy to PegIFN alfa-2a in patients with HBeAg-positive chronic hepatitis B: A randomized trial

Real-Life Effectiveness and Safety of Glecaprevir/Pibrentasvir for Korean Patients with Chronic Hepatitis C at a Single Institution

Efficacy and Safety of Glecaprevir/Pibrentasvir in Korean Patients with Chronic Hepatitis C: A Pooled Analysis of Five Phase II/III Trials

Safety, tolerability and antiviral activity of the antisense oligonucleotide bepirovirsen in patients with chronic hepatitis B: a phase 2 randomized controlled trial

Peretinoin, an Acyclic Retinoid, for the Secondary Prevention of Hepatocellular Carcinoma

Overcoming Tumor Resistance to Oncolyticvaccinia Virus with Anti-PD-1-Based Combination Therapy by Inducing Antitumor Immunity in the Tumor Microenvironment

Collaborators (7)

Ki Tae Yoon

hyung hoi kim

So Young Yoo

PIETRO ANDREONE

Anthony Brown

Enrico N De Toni

Carla S. Coffin

Make your next move.